Prepolarized MRI at Earth Field to seek new contrasts linked to molecular events for very early detection of pathologies

Discover the project

PrimoGAIA

PrimoGaia opens up a new pathway in Magnetic Resonance Imaging (MRI) by initiating the concept of in vivo “enzymatic imaging” for a better understanding of human physiology, early detection and prognosis of diseases, monitoring of therapeutic treatment.

The project

7 partners
4 countries
H2020 FET Open
Start: 01-12-2019
end: 31-05-2023

News
#magnetic resonance imaging (MRI), #dynamic nuclear polarization (DNP), #overhauser MRI (OMRI), #enzyme activity, #ultra-low field, #contrast agents, #inflammatory diseases, #enzymatic mapping, #cost efficient sytems, #medical engineering
PrimoGAIA Interviews – Sabrina Elkhanoufi
PrimoGAIA Interviews - Sabrina Elkhanoufi
...
PrimoGAIA Interviews – Florian Fidler
PrimoGAIA Interviews - Florian Fidler
...
PrimoGAIA Interviews – Dahmane Boudries
PrimoGAIA Interviews - Dahmane Boudries
...
PrimoGAIA Interviews – Sarah Garifo
PrimoGAIA Interviews - Sara Garifo
...
PrimoGAIA Interviews – Seda Seren
PrimoGAIA Interviews - Seda Seren
...
Chemistry – A European Journal: Highly Sensitive “Off/On” EPR Probes to Monitor Enzymatic Activity
Published in Chemistry Europe
...
PrimoGAIA 2nd Review meeting
The 2nd PrimoGAIA Project Review meeting was successfully held on 26th January 2022.
...
Nanoscale journal: Functionalized silica nanoplatform as a bimodal contrast agent for MRI and optical imaging
Published in the Nanoscale journal
...
Journal of Magnetic Resonance: Enzymatic activity monitoring through dynamic nuclear polarization in Earth magnetic field
Published in the Journal of Magnetic Resonance
...